Handelsbanken Fonder AB Cuts Stake in McKesson Corporation $MCK

Handelsbanken Fonder AB lowered its stake in shares of McKesson Corporation (NYSE:MCK) by 22.1% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 168,866 shares of the company’s stock after selling 48,043 shares during the period. Handelsbanken Fonder AB owned approximately 0.14% of McKesson worth $130,456,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also modified their holdings of the company. J.W. Cole Advisors Inc. lifted its stake in shares of McKesson by 35.3% during the third quarter. J.W. Cole Advisors Inc. now owns 5,089 shares of the company’s stock worth $3,931,000 after purchasing an additional 1,329 shares in the last quarter. Private Wealth Partners LLC boosted its stake in shares of McKesson by 5.6% during the 3rd quarter. Private Wealth Partners LLC now owns 31,841 shares of the company’s stock valued at $24,598,000 after buying an additional 1,682 shares during the last quarter. AlphaQuest LLC boosted its stake in McKesson by 91.2% during the 3rd quarter. AlphaQuest LLC now owns 1,767 shares of the company’s stock valued at $1,365,000 after acquiring an additional 843 shares during the last quarter. CW Advisors LLC lifted its position in shares of McKesson by 282.5% during the second quarter. CW Advisors LLC now owns 11,008 shares of the company’s stock worth $8,067,000 after purchasing an additional 8,130 shares during the last quarter. Finally, Envestnet Asset Management Inc. grew its position in shares of McKesson by 12.4% in the 3rd quarter. Envestnet Asset Management Inc. now owns 330,647 shares of the company’s stock worth $255,438,000 after acquiring an additional 36,451 shares in the last quarter. 85.07% of the stock is owned by institutional investors and hedge funds.

More McKesson News

Here are the key news stories impacting McKesson this week:

• Positive Sentiment: Quarterly results showed revenue and operating profit ahead of expectations and management set FY‑2026 EPS guidance (38.80–39.20), reinforcing upward revisions to earnings expectations and investor confidence. A Look At McKesson (MCK) Valuation After Strong Earnings And Growing Analyst Optimism
• Positive Sentiment: Barclays raised its price target to $1,050 (from $960) and kept an Overweight rating, signaling continued analyst support that can attract additional fund buying. Barclays Boosts McKesson (MCK) Price Target, Says Shares Likely to Stay in Favor
• Positive Sentiment: Large institutional inflows have been a key technical driver this year; “big money” accumulation is cited as a reason for the stock’s strong multi‑month run and elevated relative performance. See How Institutional Inflows Make McKesson Fly
• Positive Sentiment: Shares reached an all‑time high, reinforcing momentum and likely triggering additional momentum/quant buying and headline attention. McKesson stock hits all-time high at 972.06 USD
• Neutral Sentiment: Coverage consensus is constructive (e.g., a “Moderate Buy” consensus from brokerages), but valuation metrics (P/E ~28, strong YTD gains) are noted — suggesting upside is supported but the stock could be sensitive to any guidance hiccups or macro shocks. McKesson Corporation (NYSE:MCK) Receives Consensus Rating of “Moderate Buy” from Brokerages

Analyst Ratings Changes

Several analysts have weighed in on the stock. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating on shares of McKesson in a research note on Wednesday, December 10th. Evercore reaffirmed an “outperform” rating and set a $1,000.00 price objective on shares of McKesson in a research report on Thursday, November 6th. UBS Group raised their target price on shares of McKesson from $920.00 to $980.00 and gave the stock a “buy” rating in a report on Thursday, November 6th. Weiss Ratings lowered McKesson from a “buy (a-)” rating to a “buy (b+)” rating in a report on Thursday, February 5th. Finally, TD Cowen raised their price target on McKesson from $1,000.00 to $1,012.00 and gave the stock a “buy” rating in a report on Thursday, February 5th. Thirteen equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $943.50.

McKesson Price Performance

Shares of MCK stock opened at $973.59 on Friday. McKesson Corporation has a 12-month low of $619.48 and a 12-month high of $977.27. The firm has a market capitalization of $119.26 billion, a price-to-earnings ratio of 28.00, a price-to-earnings-growth ratio of 1.55 and a beta of 0.40. The business has a 50 day simple moving average of $865.48 and a 200 day simple moving average of $803.36.

McKesson (NYSE:MCK) last announced its quarterly earnings results on Wednesday, February 4th. The company reported $9.34 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $9.19 by $0.15. The company had revenue of $106.16 billion during the quarter, compared to analyst estimates of $105.98 billion. McKesson had a negative return on equity of 338.97% and a net margin of 1.09%.The firm’s quarterly revenue was up 11.4% on a year-over-year basis. During the same quarter in the previous year, the firm posted $8.03 EPS. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. On average, equities analysts anticipate that McKesson Corporation will post 32.77 EPS for the current fiscal year.

McKesson Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, April 1st. Shareholders of record on Monday, March 2nd will be given a $0.82 dividend. This represents a $3.28 dividend on an annualized basis and a yield of 0.3%. The ex-dividend date is Monday, March 2nd. McKesson’s dividend payout ratio is 9.43%.

Insider Transactions at McKesson

In other news, EVP Thomas L. Rodgers sold 276 shares of McKesson stock in a transaction on Monday, January 5th. The stock was sold at an average price of $816.18, for a total transaction of $225,265.68. Following the transaction, the executive vice president directly owned 2,268 shares in the company, valued at approximately $1,851,096.24. This trade represents a 10.85% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CAO Napoleon B. Rutledge, Jr. sold 328 shares of the business’s stock in a transaction on Friday, February 6th. The stock was sold at an average price of $955.00, for a total value of $313,240.00. The SEC filing for this sale provides additional information. In the last 90 days, insiders sold 1,143 shares of company stock valued at $1,046,070. Company insiders own 0.08% of the company’s stock.

About McKesson

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.